NCT06986824

Brief Summary

There is limited research on the optimal strategy to reduce obstetric laceration, postpartum urinary retention, and postpartum pelvic pain. In systematic reviews, clinician-directed massage of the perineal muscles at the time of birth and patient directed massage of the perineal muscles in the third trimester to inconsistently reduce the incidence of severe obstetric laceration.1,2 However, there is significant heterogeneity of these studies is due in large part to the lack of a standardized protocols and unpredictability of clinician availability to perform perineal massage around the time of birth. The purpose of this study is to understand how perineal massage with a pelvic wand in late pregnancy and during labor influences one's sense of self-control over the labor process and birth experience.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for phase_4

Timeline
4mo left

Started Oct 2025

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Oct 2025Sep 2026

First Submitted

Initial submission to the registry

May 14, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 23, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Expected
Last Updated

March 9, 2026

Status Verified

March 1, 2026

Enrollment Period

6 months

First QC Date

May 14, 2025

Last Update Submit

March 6, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mean score difference between the two arms on the Labor Agentry Scale

    A clinically significant difference is defined as a mean score difference of 10 points

    During hospitalization (assessed up to 5 days)

Secondary Outcomes (6)

  • The average number of completed massage sessions prior to hospitalization

    6-8 weeks prior to birth event

  • The average number of completed massage sessions during hospitalization

    24-48 hours

  • The average number of completed massage sessions postpartum

    6 weeks post birth time point

  • Number of patients with postpartum urinary symptoms

    12 weeks postpartum

  • Number of patients with pelvic floor dysfunction in the postpartum period

    6 weeks postpartum and 12 week postpartum

  • +1 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

The intervention arm will receive standard of care education about the benefits of perineal massage and receive instruction to perform the massage three times weekly. They will then watch a 2-minute video to demonstrate proper use and cleaning of the device to assist with antepartum perineal massage. Trained study personnel will also be available to answer questions on proper use, storage, and cleaning. Participants will be provided with the pelvic wand at enrollment and asked to use the device at least three times weekly for 10 minutes beginning at enrollment until their hospitalization for birth. This frequency and duration are what is recommended by pelvic floor physical therapists and is their standard of care.

Device: Pelvic wand

Control

NO INTERVENTION

The control arm will receive standard of care verbal education about the benefits of self-directed (or partner) manual perineal massage in the antepartum period and during the birthing process. They will be given the device after birth before hospital discharge.

Interventions

Use of a pelvic wand to perform perineal massage

Intervention

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant
  • Plan to give birth at BIDMC
  • Age ≥18 years old
  • English language preference
  • weeks 'gestation

You may not qualify if:

  • Contraindication to vaginal birth, active genital herpes infection, fetal anomaly requiring cesarean birth).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02115, United States

RECRUITING

Related Publications (3)

  • Eason E, Labrecque M, Wells G, Feldman P. Preventing perineal trauma during childbirth: a systematic review. Obstet Gynecol. 2000 Mar;95(3):464-71. doi: 10.1016/s0029-7844(99)00560-8.

    PMID: 10711565BACKGROUND
  • Aasheim V, Nilsen ABV, Reinar LM, Lukasse M. Perineal techniques during the second stage of labour for reducing perineal trauma. Cochrane Database Syst Rev. 2017 Jun 13;6(6):CD006672. doi: 10.1002/14651858.CD006672.pub3.

    PMID: 28608597BACKGROUND
  • Hodnett ED, Simmons-Tropea DA. The Labour Agentry Scale: psychometric properties of an instrument measuring control during childbirth. Res Nurs Health. 1987 Oct;10(5):301-10. doi: 10.1002/nur.4770100503.

    PMID: 3671777BACKGROUND

MeSH Terms

Conditions

Pelvic Floor DisordersWounds and InjuriesPatient Participation

Condition Hierarchy (Ancestors)

Female Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPregnancy ComplicationsMale Urogenital DiseasesPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Sarah Little, MD

    Beth Israel Deaconess Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ethan Litman, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This is a randomized study with an intention-to-treat analysis with an intervention and control arm.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Fellow in Obstetrics, Gynecology and Reproductive Biology

Study Record Dates

First Submitted

May 14, 2025

First Posted

May 23, 2025

Study Start

October 1, 2025

Primary Completion

April 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

March 9, 2026

Record last verified: 2026-03

Locations